Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Sabra Health Care REIT Inc (SBRA): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Page 1 of 2

In the financial world, there are plenty of metrics shareholders can use to watch stocks. Two of the best are hedge fund and insider trading sentiment. At Insider Monkey, our research analyses have shown that, historically, those who follow the best picks of the best money managers can outclass the S&P 500 by a very impressive margin (see just how much).

Equally as useful, positive insider trading sentiment is another way to analyze the financial markets. Just as you’d expect, there are lots of motivations for an upper level exec to cut shares of his or her company, but only one, very simple reason why they would buy. Several academic studies have demonstrated the impressive potential of this strategy if “monkeys” understand where to look (learn more here).

Furthermore, let’s analyze the latest info for Sabra Health Care REIT Inc (NASDAQ:SBRA).

Sabra Health Care REIT Inc (NASDAQ:SBRA)

What does the smart money think about Sabra Health Care REIT Inc (NASDAQ:SBRA)?

At the end of the second quarter, a total of 12 of the hedge funds we track were long in this stock, a change of 100% from one quarter earlier. With the smart money’s positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were boosting their holdings substantially.

According to our 13F database, J. Alan Reid, Jr.’s Forward Management had the biggest position in Sabra Health Care REIT Inc (NASDAQ:SBRA), worth close to $22.2 million, comprising 1.9% of its total 13F portfolio. Coming in second is Cliff Asness of AQR Capital Management, with a $9.4 million position; the fund has less than 0.1%% of its 13F portfolio invested in the stock. Some other peers that hold long positions include Israel Englander’s Millennium Management, Dmitry Balyasny’s Balyasny Asset Management and Millennium Management Subsidiary’s Decade Capital Management.

Consequently, specific money managers were breaking ground themselves. Forward Management, managed by J. Alan Reid, Jr., established the biggest position in Sabra Health Care REIT Inc (NASDAQ:SBRA). Forward Management had 22.2 million invested in the company at the end of the quarter. Cliff Asness’s AQR Capital Management also made a $9.4 million investment in the stock during the quarter. The other funds with brand new SBRA positions are Israel Englander’s Millennium Management, Dmitry Balyasny’s Balyasny Asset Management, and Millennium Management Subsidiary’s Decade Capital Management.

What have insiders been doing with Sabra Health Care REIT Inc (NASDAQ:SBRA)?

Legal insider trading, particularly when it’s bullish, is most useful when the primary stock in question has experienced transactions within the past half-year. Over the last 180-day time frame, Sabra Health Care REIT Inc (NASDAQ:SBRA) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Sabra Health Care REIT Inc (NASDAQ:SBRA). These stocks are Healthcare Realty Trust Inc (NYSE:HR), Medical Properties Trust, Inc. (NYSE:MPW), National Health Investors Inc (NYSE:NHI), Universal Health Realty Income Trust (NYSE:UHT), and LTC Properties Inc (NYSE:LTC). All of these stocks are in the reit – healthcare facilities industry and their market caps are closest to SBRA’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!